Cargando…
Impact of Amending the Acetylcysteine Marketing Authorisation on Treatment of Paracetamol Overdose
In September 2012, the Medicines and Healthcare products Regulatory Agency (MHRA) substantially amended the Marketing Authorisation for acetylcysteine following an extensive review. The present study examined the impact of this license change on patterns of acetylcysteine use in patients presenting...
Autores principales: | Thompson, G., Fatima, S. B., Shah, N., Kitching, G., Waring, W. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730223/ https://www.ncbi.nlm.nih.gov/pubmed/23956882 http://dx.doi.org/10.1155/2013/494357 |
Ejemplares similares
-
Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose
por: Pettie, Janice M., et al.
Publicado: (2019) -
Efficacy of a two bag acetylcysteine regimen to treat paracetamol overdose (2NAC study)
por: Wong, Anselm, et al.
Publicado: (2020) -
Delayed presentation of paracetamol overdose
por: Els, Johnre Retief, et al.
Publicado: (2020) -
A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose
por: Kalsi, Sarbjeet S, et al.
Publicado: (2011) -
Paracetamol overdose: Acute liver failure and acute kidney injury following an overdose of paracetamol: case report
Publicado: (2020)